Results 171 to 180 of about 34,760 (297)

Incidental Myocardial Bridging Coinciding With Myocardial Ischemia and Takotsubo Cardiomyopathy in an Asymptomatic Patient. [PDF]

Cureus
Khan MZ, Patil A, Suleiman M, Karr J.
europepmc   +1 more source

Microglial Activation Under Hypoxic Conditions in Early Alzheimer's Disease: Can Natural SIRT1 Activators Be Therapeutic Allies in the Inflammation–Energy Axis?

Phytotherapy Research, EarlyView.
ABSTRACT Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by a preclinical stage that typically lasts for decades. Early on during this time, microglia react to pathological changes and become protective and even transiently delay neurodegeneration.
Sara Merlo, Cristiana Lucia Rita Lipari, Aurora Patti, Maria Angela Sortino   +3 more
wiley   +1 more source

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers

Journal of the American Heart Association, EarlyView., 2021
Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments.
Rebecca K. Hughes, Claudia Camaioni, João B. Augusto, Kristopher Knott, Ellie Quinn, Gabriella Captur, Andreas Seraphim, George Joy, Petros Syrris, Perry M. Elliott, Saidi Mohiddin, Peter Kellman, Hui Xue, Luis R. Lopes, James C. Moon   +14 more
wiley   +1 more source

A Tough Bridge to Cross: Myocardial Bridging Associated With Dehydration-Induced Ischemia in an Endurance Athlete. [PDF]

Cureus
LaGalbo SA, Rao A, Swearingen SP.
europepmc   +1 more source

Staging concept for aging management: Definition, mechanism, and coping strategies

VIEW, EarlyView.
We divided the overall aging stage into “pre‐aging”, “aging compensation”, and “aging disability”. For each stage, we delineate the clinical presentations, biological phenomena, theoretical underpinnings, and key management priorities. Abstract Aging, as a gradual and largely irreversible biological process, characterized by declining organismal ...
Zhonghan Wang, Shixian Liu, Shangyu Du, Xiangran Cui, Bo Chao, Minglei Liu, Minfei Wu   +6 more
wiley   +1 more source

Nitroglycerin-Induced Coronary Collapse in a Patient With Myocardial Bridging. [PDF]

JACC Case Rep
Ramsarran R, Hughes S.
europepmc   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

Fundamental Anatomy and Its Impact on Clinical Practice: Myocardial Bridging. [PDF]

JACC Case Rep
Ortega-Pérez R, Ibañez B, Sánchez-Quintana D, Cabrera JÁ.   +3 more
europepmc   +1 more source

Hospital Costs Associated With Mechanical Left Ventricular Unloading Devices During VA ECMO for Adult Cardiogenic Shock

Artificial Organs, EarlyView.
In a cohort of patients with cardiogenic shock supported with V‐A ECMO, the addition of left ventricular mechanical unloading was associated with higher median hospitalization costs ($390 508 vs. $320 269), longer hospital length of stay (IRR 1.06, p < 0.001), and lower mortality compared with VA ECMO alone (HR 0.62, p = 0.006).
Maxwell A. Hockstein, Joshua J. Horns, Thomas Hanff, Iosif Taleb, Craig Selzman, Stavros Drakos, Richard Nelson, Joseph E. Tonna   +7 more
wiley   +1 more source

Clinical outcomes of FFR and IVUS-guided PCI in patients with myocardial bridging and proximal LAD stenosis. [PDF]

Front Cardiovasc Med
Wu X, Wu M, Huang H, Liu Z, Huang H, Wang L.   +5 more
europepmc   +1 more source